Topic Hub
15 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 15 of 15 clinical reviews.
A clinician-reviewed guide covering how empagliflozin affects daily activities, exercise, cognitive function, and safety for adults aged 65 and older, with dosing guidance and fall-risk strategies.
Read clinical reviewA clinician-reviewed deep dive into off-label empagliflozin use in adolescents ages 12 to 17, covering the evidence base, dosing considerations, safety profile, and how prescribers manage FDA labeling gaps.
Read clinical reviewA physician-reviewed guide to empagliflozin use in geriatric patients aged 65+, covering off-label applications, trial data, renal and cardiovascular considerations, and dosing safety in older adults.
Read clinical reviewA clinical deep-dive into empagliflozin off-label use in pediatric patients under age 12, covering evidence, safety data, dosing considerations, and FDA approval status.
Read clinical reviewA clinical guide for parents, school nurses, and caregivers on managing empagliflozin (Jardiance) in children under 12, covering hydration, DKA risk, PE class, sports, and school health plans.
Read clinical reviewA clinically grounded guide for teens aged 12-17 taking empagliflozin (Jardiance): what to tell the school nurse, how exercise affects blood sugar, hydration needs, and how to stay safe during sports and field trips.
Read clinical reviewA clinical guide to transitioning adolescents (ages 12-17) taking Jardiance (empagliflozin) into adult diabetes care, covering dosing, monitoring, safety, and handoff protocols.
Read clinical reviewA complete caregiver guide to giving Jardiance (empagliflozin) to adolescents aged 12 to 17, covering dosing, timing, food interactions, missed doses, storage, and when to call the prescriber.
Read clinical reviewA clinician-reviewed guide for caregivers managing empagliflozin (Jardiance) in patients 65+, covering dosing, hydration, fall risk, UTI monitoring, and when to call the prescriber.
Read clinical reviewA clinician-reviewed guide to empagliflozin (Jardiance) use in adults 65+, covering dose adjustments, safety monitoring, care-transition protocols, and evidence from EMPA-REG OUTCOME and EMPEROR-Reduced.
Read clinical reviewA comprehensive clinical review of empagliflozin (Jardiance) use in adults aged 65 and older, covering cardiovascular outcomes, renal protection, volume-depletion risks, dosing considerations, and how EMPA-REG OUTCOME data translates to geriatric practice.
Read clinical reviewA physician-reviewed guide to how empagliflozin (Jardiance) affects growth, bone health, puberty, and metabolic development in adolescents ages 12 to 17, with trial data, dosing guidance, and safety monitoring protocols.
Read clinical reviewA physician-reviewed guide to empagliflozin (Jardiance) use in pediatric patients under age 12, covering FDA approval status, safety data, dosing considerations, and how to plan the handoff to adult endocrinology care.
Read clinical reviewA complete caregiver guide to giving Jardiance (empagliflozin) to children under 12, covering approved indications, dosing, oral solution preparation, missed doses, side effects, and when to call the doctor.
Read clinical reviewA clinical review of empagliflozin (Jardiance) use in children under 12, covering FDA approval status, developmental safety concerns, growth effects, and what families need to know before considering this SGLT2 inhibitor in young patients.
Read clinical review